Ikarian Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-201,187
| Closed | -$760K | – | 122 |
|
|
2024
Q4 | $760K | Sell |
201,187
-73,364
| -27% | -$277K | 0.1% | 76 |
|
|
2024
Q3 | $890K | Hold |
274,551
| – | – | 0.12% | 58 |
|
|
2024
Q2 | $522K | Sell |
274,551
-56,900
| -17% | -$108K | 0.09% | 68 |
|
|
2024
Q1 | $941K | Sell |
331,451
-546,049
| -62% | -$1.55M | 0.1% | 59 |
|
|
2023
Q4 | $12.9M | Buy |
+877,500
| New | +$12.9M | 1.21% | 8 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 84 |
|
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$293K | – | 86 |
|
|
2023
Q1 | $293K | Buy |
+10,000
| New | +$293K | 0.07% | 75 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 69 |
|
|
2022
Q3 | – | Sell |
-246,554
| Closed | -$4.75M | – | 69 |
|
|
2022
Q2 | $4.75M | Sell |
246,554
-150,100
| -38% | -$2.89M | 0.87% | 18 |
|
|
2022
Q1 | $5.1M | Buy |
+396,654
| New | +$5.1M | 0.67% | 23 |
|